Fig. 6

Targeted NGS futher validated based on the spectrum of DNA alterations and EGFR hotspot mutation rates in a large non-small-cell lung cancer (NSCLC) cohort. (a) Gene alterations were found in 215 cases of NSCLC by targeted NGS. (b) Hotspot mutations in EGFR were identified by targeted NGS platform in 121 NSCLC samples